Mevalonate pathway-triggered phase transition of injectable hydrogel for cholesterol-downregulated therapy of osteoarthritis
Dysregulation of mevalonate pathway, an essential metabolic route involving coenzyme A (CoASH) and cholesterol, contributes significantly to escalating cartilage degradation. Existing treatments rely on the simvastatin delivery via tunable sol-gel transition mechanisms of injectable hydrogel. Howeve...
Saved in:
| Main Authors: | Akhmad Irhas Robby, Ee Hyun Kim, Kang Moo Huh, Eun-Jung Jin, Ki Dong Park, Sung Young Park |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-09-01
|
| Series: | Bioactive Materials |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2452199X2500283X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Distinct Phenotype of Mevalonic Acidemia with Absence of Pathogenic Mutations of Mevalonate Kinase Gene
by: Imad Dweikat, et al.
Published: (2016-03-01) -
Intrauterine intestinal obstruction in a preterm infant with severe mevalonate kinase deficiency – a case report
by: Henrike Hoermann, et al.
Published: (2025-03-01) -
Mevalonate kinase deficiency: genetic and clinical characteristics of a Chinese pediatric cohort
by: Chenchen Guan, et al.
Published: (2025-07-01) -
Mevalonate kinase deficiency syndrome: Single center experience
by: A. L. Kozlova, et al.
Published: (2021-07-01) -
PERIODIC FEVER SYNDROME (MEVALONATE KINASE DEFICIENCY, HYPERIMMUNOGLOBULINEMIA D SYNDROME) IN CHILDREN
by: Yu. S. Patrusheva, et al.
Published: (2012-03-01)